The benchmark S&P/ASX 200 closed slightly lower today, but still managed to log a decent gain for the week. The standout ...

Bell Potter analyst Thomas Wakim maintained a Buy rating on Opthea Limited (CKDXF – Research Report) today and set a price target of A$1.30.

The ASX200 pared early gains and closed up 0.48% at 8,231 points. A lift in the iron ore price has driven big miners higher; ...

Opthea Limited Sponsored ADR (OPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

The Company has received a copy of the Public Announcement issued by Ambuja Cements Limited in connection with its Open offer. For details, please refer attached file. SBI Capital Markets Ltd ...

Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a ...

We think a stock that really fits the bill here is one called Opthea. Opthea is targeting approval for a drug which addresses eye disease called wet age-related macular degeneration or wet AMD. This ...

Nickel continued to lead the revived base metal market during the Aug. 4-10 report period, with prices climbing 12 cents to US$2.91 per lb. thanks to a combination of growing demand, shrinking stocks ...

Opthea Limited announced it will host an Investor Day on January 28, 2025, in New York City, where the company will provide updates on its lead product candidate, sozinibercept, aimed at treating ...

Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...